REQUEST A DEMO
Total
USD $0.00
Search more companies

Biotronik Baltija SIA (Latvia)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Biotronik Baltija SIA Profile Updated: July 24, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English & Russian Download a sample report

Biotronik Baltija SIA is a company based in Latvia, with its head office in Riga. The enterprise currently operates in the Drugs and Druggists' Sundries Merchant Wholesalers sector. It was established on September 09, 1996. 4 (2023) employees currently work for Biotronik Baltija SIA. There was a net sales revenue increase of 15.45% reported in Biotronik Baltija SIA’s latest financial highlights for 2025. Its’ total assets recorded a growth of 28.92%. Biotronik Baltija SIA’s net profit margin increased by 11% in 2025.

Headquarters
Kalnciema iela 37 - 4
Riga; Riga; Postal Code: 1046

Contact Details: Purchase the Biotronik Baltija SIA report to view the information.

Basic Information
Total Employees:
Purchase the Biotronik Baltija SIA report to view the information.
Registered Capital:
Purchase the Biotronik Baltija SIA report to view the information.
Financial Auditors:
Purchase the Biotronik Baltija SIA report to view the information.
Incorporation Date:
September 09, 1996
Key Executives
Purchase this report to view the information.
Chairman of the Supervisory Board
Purchase this report to view the information.
Member of Management Board
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Biotronik Baltija SIA report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency EUR. Absolute financial data is included in the purchased report.
Net sales revenue
15.45%
Total Operating Revenue
16.42%
Operating Profit
395.99%
Net Profit/Loss for the Period
371.9%
Total Assets
28.92%
Total Equity
35.24%
Operating Profit Margin
11.45%
Net Profit Margin
11%
Return on Equity (ROE)
18.59%
Quick Ratio
3.6%
Cash Ratio
-1.19%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?